Russell Investments Group’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
17,990
+14,315
+390% +$102K ﹤0.01% 3358
2026
Q1
$24.6K Sell
3,675
-61
-2% -$350 ﹤0.01% 3557
2025
Q4
$20.4K Hold
3,736
﹤0.01% 3622
2025
Q3
$23.1K Buy
3,736
+3,495
+1,450% +$22.9K ﹤0.01% 3553
2025
Q2
$1.51K Sell
241
-126
-34% -$737 ﹤0.01% 3619
2025
Q1
$2.15K Buy
367
+181
+97% +$1.37K ﹤0.01% 3506
2024
Q4
$1.53K Sell
186
-5
-3% -$47 ﹤0.01% 3482
2024
Q3
$1.7K Sell
191
-51
-21% -$437 ﹤0.01% 3401
2024
Q2
$1.83K Buy
+242
New +$1.77K ﹤0.01% 3362

Other funds holding AURA

Russell Investments Group's AURA Position: Q2 2026 in Review

Russell Investments Group increased its Aura Biosciences (AURA) stake by 390% in Q2 2026, buying an estimated $102K and bringing the position to 17,990 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3358.

Russell Investments Group first reported a position in AURA in Q2 2024 and has held it in 9 quarters since. 44 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Russell Investments Group held 17,990 shares of Aura Biosciences worth $128K as of Q2 2026.
  • Russell Investments Group bought 14,315 Aura Biosciences shares in Q2 2026, an estimated $102K.
  • Aura Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3358 holding.
  • Russell Investments Group first reported a position in Aura Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 44 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.